Legal and regulatory risks relating to mail-order sales
First written in FY2017. 4 of 5 entries say "Restated". Latest entry: FY2023.
The whole theme swung hardest in 2025: 6 of 29 companies on the "Worse" side.
50 other companies' latest entry also says "Restated".
- FY2023RestatedAnnual report
「Our group has established a framework for complying with these laws through measures including the development of a management framework. However, any violation of these laws, amendments to them or enactment of new laws may affect the group’s business and performance.」
Continues to address the risks of violations of, amendments to and enactment of new laws relating to mail-order sales, together with responses through the management framework. - FY2021RestatedAnnual report
「Our group has established a framework for complying with these laws through measures including the development of a management framework. However, any violation of these laws, amendments to them or enactment of new laws may affect the group’s business and performance.」
Continues to address the risks of violations of, amendments to and enactment of new laws relating to mail-order sales, together with responses through the management framework. - FY2020RestatedAnnual report
「The group has established systems for complying with these laws through measures including the development of appropriate control systems. However, if violations occur, or if laws are amended or new laws enacted, the group’s business and performance may be affected.」
Continues to address the risks of violations of, amendments to and enactment of new laws relating to mail-order sales, together with responses through the management framework. - FY2019RestatedAnnual report
「This business is subject to legal regulations under the Act on Specified Commercial Transactions, Consumer Contract Act, Act against Unjustifiable Premiums and Misleading Representations, Product Liability Act, Act on the Prevention of Delays in Payment of Subcontracting Charges and Related Matters to Subcontractors, and Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices, among others.」
Continues to describe the possibility that violations of laws relating to mail-order sales, legal amendments and the enactment of new laws may affect the business and performance. - FY2017First statedAnnual report
「This business is subject to legal regulations under the Act on Specified Commercial Transactions, Consumer Contract Act, Act against Unjustifiable Premiums and Misleading Representations, Product Liability Act, Act on the Prevention of Delays in Payment of Subcontracting Charges and Related Matters to Subcontractors, and Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices, among others.」
Describes the possibility that violations of multiple laws relating to mail-order sales, legal amendments and the enactment of new laws may affect the business and performance.